The US Centers for Disease Control and Prevention (CDC) says there is no evidence that the vaccine will help to protect people from hospitalisation after they get infected with COVID.

The agency says people who already have the virus but have not had an infection will have to get a vaccine.

It says it will not cover people who are on treatment, who have already had an HIV diagnosis, or who are immunosuppressed, and will not include people who have received vaccines or who have taken other medications.

A CDC spokesperson told CBC News that there are “many questions” to answer about the efficacy of the vaccine and how well it protects against complications such as convulsions, which can occur with the vaccine.

The spokesperson added that the CDC would not provide a timeline for when the agency will issue a statement about the COVID vaccine.

In a statement to CBC News, the CDC said the US vaccine is designed to be given “at least twice a year, regardless of the person’s history of infection”.

“There is no information to indicate that there will be any increased incidence of hospitalisations associated with the COV-19 pandemic.

We do not have a timeline on when this will happen or when the public will be able to obtain the vaccine,” the CDC spokesperson said.

The US has received more than 1.6 million doses of the COID-19-1 vaccine, which is manufactured by Pfizer, and more than 4.6 billion doses have been administered in the United States.

The vaccine is being distributed to patients at the University of Minnesota, and the state of Minnesota is providing a trial of the new vaccine.

But it was not clear whether the trial would be a success.

Some health experts are questioning the effectiveness of the vaccines.

“The efficacy of COVID vaccines is not well established,” said Dr. Stephen Fagan, an infectious disease physician at the Mayo Clinic.

“And I think that the safety issues associated with COV vaccines are much bigger than the efficacy issues.”

Fagan said the safety of the newer vaccine could be further examined by testing it on a larger number of people.

“If it’s showing up as being effective against the virus, it may be that that’s because the vaccine has been given to a larger population, and that could be the case,” he said.

“But we don’t know that.”

Faggans group has a vaccine safety panel, which he chairs, that is reviewing the safety and efficacy of all the COIDs vaccines.

He said he would be surprised if the COVE vaccine was safe and effective.

“I think the real question is, if it’s safe and safe, why hasn’t it been used yet?

It could be because they are not tested on a large enough number of patients, or it could be that there’s not enough data to know that, but that’s my question,” he added.

Fagan told CBC he would like to see a large-scale trial of a COVID vaccination.

He also suggested that the U.S. could consider making the vaccine available through an insurance company that covers people who cannot afford to pay for the vaccine, such as those who cannot pay for their own healthcare or who do not qualify for Medicare.

Faggan said the government could help pay for it by providing the vaccine through Medicare, and said that’s what the government should do.

“We need to make sure that Medicare has the funds to pay it.

We have the authority to do that,” he told CBC.

Fagans concerns about the effectiveness and safety of COV vaccinations were echoed by Dr. Anthony Fauci, a professor at the Johns Hopkins University School of Medicine and the author of “The New COVID,” which is based on the findings of the CDC.

Fauczis group has released a report calling for a global study to determine if COVID vaccinations are safe and that COVIDs are causing hospitalisation.

Fungal infections are becoming a concern in some parts of the world, and in Canada, there are concerns that the virus could spread to people with weakened immune systems.

Health experts say people should not get vaccinated without being given the vaccine first.

“A person should not be vaccinated because of the risk to the person, but also because of their ability to pay,” Faucci said.